Skip to content
Open access

Initial Experience with Standalone Thoracoscopic Left Atrial Appendage Occlusion Using AtriClip Pro2: A Single-Center Retrospective Cohort Study in Latvia

Sep 2026 · Medicina · Vol 62 · 0 citations · 13 references
Medicine

TL;DR

This small, heterogeneous, single-center series supports the technical feasibility of standalone thoracoscopic AtriClip Pro2 implantation in selected patients and warrants further evaluation in larger cohorts with longer clinical follow-up and standardized postoperative imaging.

Abstract

Background and Objectives: Left atrial appendage (LAA) closure is an established strategy for stroke prevention in selected patients with atrial fibrillation (AF), particularly when long-term oral anticoagulation (OAC) is contraindicated. Thoracoscopic epicardial LAA occlusion using the AtriClip Pro2 device provides a minimally invasive surgical approach; however, evidence for standalone use remains limited. This study aimed to describe the initial feasibility and early clinical outcomes of standalone thoracoscopic LAA occlusion using AtriClip Pro2 in Latvia. Materials and Methods: We performed a single-center retrospective observational study including all consecutive patients who underwent standalone thoracoscopic LAA occlusion at the Department of Cardiac Surgery, Pauls Stradins Clinical University Hospital, between December 2024 and March 2026. Baseline characteristics, procedural outcomes, perioperative complications, rehospitalizations, and antithrombotic therapy status were assessed. LAA closure was assessed by transesophageal echocardiography (TEE). Results: Fourteen patients were included. Mean age was 63.6 ± 16.7 years (median 67.0; IQR 54.8–76.8), and 64.3% were female. Thoracoscopic completion was achieved in 13/14 patients (92.9%; 95% CI 68.5–98.7%); one patient (7.1%) required conversion to median sternotomy because of intraoperative bleeding. Complete LAA exclusion without residual flow or stump was documented in all 14 patients (100%; 95% CI 78.5–100%). No perioperative stroke or mortality occurred. At three months, follow-up data were available for all patients, and antithrombotic therapy had been discontinued in 12/14 patients (85.7%). Conclusions: This small, heterogeneous, single-center series supports the technical feasibility of standalone thoracoscopic AtriClip Pro2 implantation in selected patients. These encouraging early findings warrant further evaluation in larger cohorts with longer clinical follow-up and standardized postoperative imaging.

Read PDF

Similar papers

Review Aug 2026

Percutaneous and Surgical Left Atrial Appendage Occlusion in Non-Valvular Atrial Fibrillation: Contemporary Narrative Review.

BACKGROUND Left atrial appendage occlusion (LAAO) reduces thromboembolic risk in patients with atrial fibrillation (AF) who have contraindications to oral anticoagulation (OAC). LAAO can be performed surgically (S-LAAO) or percutaneously (pLAAO), but direct comparative evidence remains limited. METHODS We conducted a...

Julian Chestaro, Hannah Price, Joel Matthews et al. · 0 citations
Open access Aug 2026

Left atrial appendage resection during thoracoscopic ablation in patients with atrial fibrillation: an own experience

Aim . To improve the quality of high-tech health care provided to patients with atrial fibrillation (AF) by performing left atrial appendage (LAA) resection with an endoscopic stapler during thoracoscopic isolation of left atrial (LA) arrhythmogenic zones. Material and methods . This article presents the surgi...

A. Bagdasaryan, T. Shcherbinin, E. Khomenko et al. · 0 citations
Review Open access Sep 2026

Persistent iatrogenic atrial septal defect after single-puncture, double transseptal access for 4D ICE-guided left atrial appendage occlusion: Incidence and clinical outcomes.

Persistent iASD is common following LAAO, occurring in 43% of patients at early follow-up, with similar rates between 2D and 4D ICE techniques.

K. Culler, Aamir Ahmed, Supreet Singh et al. · 0 citations
Open access Aug 2026

Prophylactic Surgical Left Atrial Appendage Closure in Bioprosthetic Aortic Valve Replacement: Short-Term Outcomes of Randomized Controlled LAA-CLOSURE Trial.

BACKGROUND Surgical closure of the left atrial appendage (LAA) reduces stroke risk in patients with atrial fibrillation (AF) undergoing cardiac surgery. We evaluated the safety and efficacy of prophylactic LAA closure during bioprosthetic surgical aortic valve replacement in patients without prior AF. METHODS In this...

Tuomas O. Kiviniemi, F. Halfwerk, Juan Bustamante Munguira et al. · 0 citations
Review Open access Sep 2026

Feasibility and Diagnostic Yield of Left Atrial Appendage Imaging in Comprehensive CT Stroke Protocols

Extending the CT stroke protocol to the LAA was technically feasible and did not significantly increase radiation dose, but added little diagnostic yield, and on current evidence should complement rather than replace echocardiography.

Kaitlyn E. Heintzelman, Enrique M. Carrera, Katherine Burkhardt et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.